We recently proposed that the reduced RGS2 expression we have identified during early AD progression18 increases angiotensin II receptor (AGTR2) signaling and thus contributes to hypertension, which may in part explain the comorbidity of hypertension and AD57. The gene discussed is AGTR2; the disease is Hypertension.